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Understanding the role of themicrobiota components
in either preventing or favoring enteric infections is
critical. Here, we report the discovery of a Listeria
bacteriocin, Lmo2776, which limits Listeria intestinal
colonization. Oral infection of conventional mice with
aDlmo2776mutant leads to a thinner intestinalmucus
layer and higher Listeria loads both in the intestinal
content and deeper tissues compared to WT Listeria.
This latter difference is microbiota dependent, as it is
not observed in germ-free mice. Strikingly, it is phe-
nocopied by pre-colonization of germ-free mice
beforeListeria infectionwithPrevotellacopri, anabun-
dant gut-commensal bacteria, but not with the other
commensals tested. We further show that Lmo2776
targetsP. copri and reduces its abundance. Together,
these data unveil a role for P.copri in exacerbating in-
testinal infection, highlighting that pathogens such as
Listeria may selectively deplete microbiota bacterial
species to avoid excessive inflammation.
INTRODUCTION
Prevotella is classically considered a common commensal
bacterium due to its presence in several locations of the healthyCell Host & Microbe 26, 691–701, Novem
This is an open access article under the CC BY-Nhuman body, including the oral cavity, gastrointestinal tract, uro-
genital tract, and skin (Larsen, 2017). The Prevotella genus en-
compasses more than 40 different culturable species of which
three—P. copri (Pc), P. salivae (Ps), and P. stercorea—are mem-
bers of the gut microbiota. Prevotella has been reported to be
associated with opportunistic infections, e.g., periodontitis or
bacterial vaginosis (Larsen, 2017). Moreover, Prevotella is the
major genus of one of the three reported human enterotypes
(Arumugam et al., 2011), but how Prevotella behaves in different
gut ecosystems and how it interacts with other bacteria of the
microbiota and/or with its host is not well defined. In addition,
high levels of genomic diversity within Prevotella strains of the
same species have been observed (De Filippis et al., 2019;
Gupta et al., 2015), which adds another layer of complexity for
predicting the effects of Prevotella strains. Recent studies have
linked higher intestinal abundance of Pc to rheumatoid arthritis
(Alpizar-Rodriguez et al., 2019; Maeda et al., 2016; Scher
et al., 2013), metabolic syndrome (Pedersen et al., 2016),
low-grade systemic inflammation (Pedersen et al., 2016), and
inflammation in the context of human immunodeficiency virus
(HIV) infection (Dillon et al., 2016; Kaur et al., 2018; Lozupone
et al., 2014), suggesting that some Prevotella strains may trigger
and/or worsen inflammatory diseases (Larsen, 2017; Ley, 2016;
Precup and Vodnar, 2019).
The microbiota plays a central role in protecting the host from
pathogens, in part through colonization resistance (Buffie and
Pamer, 2013). In the case of Listeria monocytogenes (Lm), the
foodborne pathogen responsible for listeriosis, the intestinal
microbiota provides protection, as germfree mice are moreber 13, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 691
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
susceptible to infection than conventional mice (Archambaud
et al., 2013; Becattini et al., 2017). Treatment with probiotics
such as Lactobacillus paracasei CNCM I-3689 or L. casei BL23
was shown to decrease Lm systemic dissemination in orally
inoculated mice (Archambaud et al., 2012). Unravelling the inter-
actions between the host, themicrobiota, and pathogenic bacte-
ria is critical for the design of new therapeutic strategies via
manipulation of the microbiota. However, identifying specific
molecules and mechanisms used by commensals to elicit their
beneficial action is challenging due to the high complexity of
the microbiome, together with technical issues in culturing
many commensal species. In addition, cooperative interactions
between commensal species are likely to be central to the func-
tioning of the gutmicrobiota (Rakoff-Nahoum et al., 2016). So far,
mechanism or molecules underlying the impact of commensals
on the host or on the infection have been elucidated only for a
few species. For example, (i) segmented filamentous bacteria
were shown to coordinate maturation of T cell responses toward
Th17 cell induction (Gaboriau-Routhiau et al., 2009; Ivanov et al.,
2009), (ii) glycosphingolipids produced by the common intestinal
symbiont Bacteroides fragilis have been found to regulate ho-
meostasis of host intestinal natural killer T cells (An et al.,
2014), (iii) a polysaccharide A also produced by B. fragilis in-
duces and expands Il-10 producing CD4+ T cells (Mazmanian
et al., 2005; Mazmanian et al., 2008; Round and Mazmanian,
2010), (iv) the microbial anti-inflammatory molecule secreted
by Faecalibacterium prausnitzii impairs the nuclear-factor-kB
pathway (Que´vrain et al., 2016), (v)Mucispirillum schaedleri pro-
tects mice from Salmonella-induced colitis (Herp et al., 2019),
and (vi) Blautia producta restores resistance against vancomy-
cin-resistant enterococci (Kim et al., 2019).
Conversely, enteric pathogens evolved various means to
outcompete other species in the intestine and access nutritional
and spatial niches, leading to successful infection and transmis-
sion. In this regard, the contribution of bacteriocins and type VI
secretion system effectors during pathogen colonization of the
gut is an emerging field of investigation (B€aumler and Sperandio,
2016; Rolhion and Chassaing, 2016). Here, we studied the
impact of a previous unknown Lm bacteriocin (Lmo2776) on
infection, and we discovered that Pc, an abundant gut
commensal, is the primary target of Lmo2776 in both the mouse
and human microbiota and as a modulator of infection.
RESULTS
Lmo2776 Limits Lm Intestinal Colonization and
Virulence in a Microbiota-Dependent Manner
A recent reannotation of the genome of the Lm strain EGD-e re-
vealed that the lmo2776 gene, absent in the non-pathogenic
L. innocua species (Figure S1A), potentially encodes a secreted
bacteriocin of 107 amino acids (Desvaux et al., 2010; Glaser
et al., 2001), homologous to the lactococcin 972 (Lcn972)
secreted by Lactococcus lactis (Martı´nez et al., 1996) and to
putative bacteriocins of pathogenic bacteria Streptococcus
iniae (Li et al., 2014), Streptococcus pneumoniae, and Staphylo-
coccus aureus (Figure S1B). This gene belongs to a locus con-
taining two other genes, lmo2774 and lmo2775, encoding poten-
tial immunity and transport systems (Glaser et al., 2001). It is
present in lineage I strains responsible for themajority of Lm clin-692 Cell Host & Microbe 26, 691–701, November 13, 2019ical cases (Maury et al., 2016) and in some lineage II strains, such
as EGD-e (Figure S1C). Little is known about this bacteriocin
family, and studies have focused on Lcn972. Lmo2776 shares
between 38% an d 47% overall amino acid sequence similarity
with members of the Lcn972 family. Because expression of
lmo2774, lmo2775, and lmo2776 is significantly higher in station-
ary phase compared to exponential phase of EGD-e at 37C in
BHI (Figure S1D), all experiments described below were con-
ducted with Lm grown up to stationary phase.
We first examined the effect of Lmo2776 on infection. We
inoculated conventional BALB/c mice with either the WT,
the Dlmo2776, or the Lmo2776 complemented strains and
compared Lm loads in the intestinal lumen and deeper organs
(spleen and liver). We had verified that deletion of lmo2776
was not affecting expression of surrounding genes, lmo2774,
lmo2775, and lmo2777 (Figure S1E) or bacterial growth in vitro
(Figure S1F). Inoculation of mice with Dlmo2776 strain resulted
in significantly higher Lm loads in the small intestinal lumen
24 h post-inoculation (pi) compared to the WT strain (Figure 1A).
These differences persisted at 48 and 72 h pi (Figure S1G). Lm
loads of Dlmo2776 were also significantly higher in the spleen
and liver at 72 h pi compared to both WT and Lmo2776-comple-
mented strains (Figures 1B and 1C). Similar results were
observed in C57BL/6J mice (data not shown). Together, these
results indicate a key role for Lmo2776 in bacterial colonization
of intestine and deeper organs. Following intravenous inocula-
tion of BALB/c mice with WT or Dlmo2776 bacteria, bacterial
loads at 72 h pi were similar in the spleen and liver (Figure S1H),
revealing that Lmo2776 exerts its primary role during the intesti-
nal phase of infection and not later.
Considering that lmo2776 is predicted to encode a bacteriocin
and that it significantly affects the intestinal phase of infection,
we hypothesized that Lmo2776 might target intestinal bacteria,
thereby impacting Lm infection. To address the role of intestinal
microbiota in infection, we orally inoculated germfree mice with
WT or Dlmo2776 strains and compared bacterial counts 72 h
pi. Strikingly, no significant difference was observed between
WT and Dlmo2776 strains in the small intestinal content (Fig-
ure 1D) nor in spleen and liver (Figures 1E and 1F). These results
showed that the Lmo2776 bacteriocin limits the presence in the
deeper organs of WT Lm in a microbiota-dependent manner.
Lmo2776 Targets Prevotella in Mouse and Human
Microbiota
To identify which intestinal bacteria were targeted by Lmo2776,
we compared microbiota compositions of conventional mice
orally infected with WT or Dlmo2776 strains by 16S rRNA gene
sequencing. We first verified that the fecal microbiota composi-
tion of all mice was indistinguishable at day 0 (Figure 2A). As ex-
pected, the microbiota composition at day 1 pi was dramatically
altered by infection with LmWT (Figure S2A). These alterations in
microbiota composition included reduced levels of Bacteroi-
detes phylum (relative abundance before infection: 65.4% and
at day 1 pi: 42.4%) and increased levels of Firmicutes (relative
abundance before infection: 29.9% and at day 1 pi: 54.0%) (Fig-
ure S2B–S2E). The increased levels in the Firmicutesweremainly
due to an increase of the Clostridia class (relative abundance
before infection: 27.4% and at day 1 pi: 50.7%). Of note, the rela-
tive abundance of Lm was around 0.1% and cannot therefore
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Figure 1. Lmo2776 Limits Lm Virulence in a
Microbiota-Dependent Manner
(A–C) BALB/c mice were inoculated orally with
Lm WT, Dlmo2776, or Lmo2776 complemented
(p2776) bacteria. CFUs in the intestinal luminal
content (A), spleen (B), and liver (C) were assessed
at 72 h pi.
(D–F) Germfree C57BL/6J were inoculated with
Lm WT or Dlmo2776 for 72 h and CFUs in the in-
testinal luminal content (D), spleen (E), and liver (F)
were assessed. Each dot represents the value for
one mouse. Statistically significant differences
were evaluated by the Mann–Whitney test (*p <
0.05; NS, not significant).explain by itself the increased levels of Firmicutes observed be-
tween day 0 and day 1. Importantly, at 24 h and 48 h pi, intestinal
microbial compositions differed in mice orally inoculated with
Dlmo2776 strain compared to WT strain (Figure 2A). We focused
on operational taxonomic units (OTUs) for which the relative
abundance was identical before infection with Lm strains (day
3 to day 0) and was subsequently altered by at least a 2-fold
difference at day 1 pi in mice infected with Dlmo2776 compared
to mice infected with WT strain. In independent experiments, the
relative abundance of 12 OTUs was lower in mice infected with
WT strain compared to Dlmo2776 mutant (Figures 2B and 2C)
at day 1 and also at day 2 pi. Phylogenetic analyses revealed
that all these 12OTUsbelong to thePrevotella cluster (Figure 2D).
A decrease of Prevotella in mice infected with WT strain at day 1
and day 2 pi compared to mice infected with Dlmo2776 strain
was also observed by qPCR analysis using primers specific for
Prevotella (Figure 2E).
Important differences exist between mouse and human gut mi-
crobiota composition.Prevotella abundance is known to be low inCell Host & Micmouse intestinal content (< 1%), although
it can reach 80% in human gut microbiota
(Hildebrand et al., 2013; Nguyen et al.,
2015). As Lm is a human pathogen, we
searched to investigate the impact of
Lmo2776 on human gut microbiota. For
this purpose, we used a dynamic in vitro
gutmodel (mucosal-simulatorofhuman in-
testinal microbial ecosystem [M-SHIME]),
whichallowsstablemaintenanceofhuman
microbiota in vitro in absence of host cells
but in presence of mucin-covered beads
(Chassaing et al., 2017; Geirnaert et al.,
2015; Van den Abbeele et al., 2013; Van
den Abbeele et al., 2012) and therefore
allows studies on human microbiota inde-
pendently of the host responses (such as
inflammation). The microbiota of a healthy
human volunteer was inoculated to the
system which was then infected with WT
or Dlmo2776 Lm. 16S sequencing to
luminal and mucosal M-SHIME samples
indicated that before Lm inoculation, the
bacterial composition in all vessels was
similar (Figure 3A and data not shown). Incontrast, followingLmaddition, luminalmicrobial communitycom-
positions were different in vessels containingWT Lm compared to
both non-infected vessels and vessels infectedwith theDlmo2776
isogenic mutant (Figure 3A). No difference was observed in
mucosal microbial community composition. The relative abun-
dance of 7 OTUswas lower in the case of theWT strain compared
to the non-inoculated condition or upon addition of the Dlmo2776
strain (Figure 3B). These 7 OTUs all belonged to Pc species (Fig-
ure 3C), revealing that Lmo2776 targets Pc in human microbiota
in a host-independent manner.
As short-chain fatty acid (SCFA) levels serve as a classical
readout for gut microbiota metabolism and as Prevotellae are
known to produce propionate (Flint and Duncan, 2014), we
quantified SCFAs production in the luminal M-SHIME samples.
A specific decrease in propionate production upon infection
with WT Lm was observed as early as 6 h pi (Figure 3D)
compared to non-infected and Dlmo2776-infected vessels.
This difference was continuously observed up to 3 days pi, while
no significant difference was observed for butyrate, isobutyrate,robe 26, 691–701, November 13, 2019 693
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Figure 2. Lmo2776 Targets Prevotella in Mouse Microbiota
(A) Principal coordinates analysis of the weighted Unifrac distance matrix of mice infected with WT strain or Dlmo2776 at days 0, 1, and 2. Permanova: day 0,
p = 0.383; day 1, p = 0.05864; and day 2, p = 0.360.
(B) Relative abundance of 12 OTUs in gut microbiota of mice inoculated with WT or Dlmo2776 strains overtime. Each dot represents the value for one mouse.
(legend continued on next page)
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acetate and isovalerate (Figure S3). Although propionate is pro-
duced by many bacterial species, the decrease in propionate
production observed upon inoculation of M-SHIME with WT
Lm is in agreement with the decrease in Pc population.
Lmo2776 Targets Pc In Vitro
We first addressed the direct inhibitory activity of Lmo2776 on
Pc by growing Pc (DSMZ 18205 strain) at 37C in anaerobic con-
ditions in the presence of culture supernatants of Lm strains and
counting the viable CFUs on agar plates. Growth of Pc dramat-
ically decreased in the presence of the WT Lm supernatant
compared to the Dlmo2776 supernatant or medium alone (Fig-
ure 3E), suggesting that Lmo2776 is secreted and targets
directly Pc.
To definitively assess the function of Lmo2776, a peptide of 63
aa (Gly69 to Lys131) corresponding to the putative mature form
of Lmo2776 was synthesized. Its activity was first analyzed on
Pc and B. thetaiotaomicron (Bt), another prominent commensal
bacterium (Figure 3F). A dose-dependent effect of Lmo2776
peptide was observed on Pc growth, while no effect was
observed on Bt growth, demonstrating that Lmo2776 targets
Pc and notBt. We then tested the effect of the peptide on several
other intestinal bacteria, either aerobic (Enterococcus faecalis,
Escherichia coli) or anaerobic (Akkermansia muciniphila [Am])
bacteria. No effect was observed on any of these bacteria (Fig-
ure 3G). Moreover, Lmo2776 peptide did not inhibit growth
of seven other Prevotella species (Ps, P. oris, P. nigrescens,
P. pallens, P. corporis, P. melaninogenica, and P. bivia). We
next tested the peptide activity on 7 Pc isolated from healthy hu-
mans and patients. Strikingly, 6 out of the 7 strains were sensitive
to the bacteriocin (Figure 3G).
We also tested the effect of the Lmo2776 peptide on known
targets of the bacteriocins of the Lcn972 family (Bacillus subtilis
[Bs] and L. lactisMG1614). Growth of Bs decreased significantly
in presence of the peptide (Figure 3G), while no effect was
observed on L. lactis growth. Growth of Bswas also significantly
reduced in the presence of WT Lm and of Lmo2776 comple-
mented strains compared to the Dlmo2776 strain (Figures S3E
and S3F). Addition of the culture supernatant of WT Lm to Bs
significantly decreased the number of Bs compared to the addi-
tion of Dlmo2776 culture supernatant (Figure S3G) (Li et al.,
2014). Together, these results indicate that Lmo2776 is a bona
fide bacteriocin that targets both Pc and Bs in vitro.
To evaluate the effect of Lmo2776 peptide in vivo, we used an
approach previously described to bypass degradation by en-
zymes of the upper digestive tract. Conventional BALB/c mice
were inoculated intra-rectally with Lmo2776 peptide (1mg per
mice, a dose probably higher than the one produced by Lm
upon infection) or water, taken as a control. Levels of total bac-
teria, Prevotella and Am were determined by qPCR on feces
collected between 1 and 4 h pi. While no effect was observed
on the levels of total bacteria or Am, fecal levels of Prevotella
decreased following administration of Lmo2776 peptide,(C) Heat-map analysis of the relative abundance of 12 OTUs in gut microbiota of m
The red and blue shades indicate high and low abundance.
(D) Phylogenetic tree of 16S rRNA gene alignment of 5 representative bacteria for
different relative abundances in gut microbiota of mice infected with WT or Dlmo
(E) PCR quantification of Prevotella in feces of mice inoculated with WT strain orshowing that similar to bacteria, Lmo2776 alone was effective
in reducing Pc in vivo (Figure 3H).
Colonization of Germfree Mice by Pc Phenocopies the
Effect of the Microbiota on Lm Intestinal Growth in
Conventional Mice
To decipher the role of Pc during Lm infection in vivo, germfree
C57BL/6J mice were orally inoculated with either Pc (DSMZ
18205 strain), Bt or Ps, another Prevotella present in the gut, or
stably colonized with a consortium of 12 bacterial species
(termed Oligo-Mouse-Microbiota (Oligo-MM12), representing
members of the major bacterial phyla in murine gut (Brugiroux
et al., 2016)). Two weeks after colonization, mice were orally
inoculated with WT Lm or Dlmo2776 strains and Lm loads in
the intestinal lumen and target organs were compared 72 h pi.
Compared to WT strain, Dlmo2776 mutant strain displayed
significantly higher loads in the intestinal lumen (Figure 4A),
spleen (Figure 4B) and liver (Figure S4) in mice colonized with
Pc, while no difference between the two strains was observed
in mice precolonized with Bt, Ps or the OligoMM12 consortium.
In addition, the number of Pc significantly decreased inWT inoc-
ulated Pc-colonized animals compared to Dlmo2776-inoculated
animals (Figure 4C). Altogether, these results indicate that the
greater ability of the Dlmo2776 mutant to grow in intestine and
reach deeper tissues compared to the WT strain correlates
with the presence of Prevotella in the microbiota, as it is
observed in either conventional mice or mice colonized with
Pc. We cannot exclude that the production of the bacteriocin
against Prevotella in vivo and at 3 days pi has a fitness cost for
Lm strains.
Pc Modifies the Mucus Layer
The intestinal mucus layer forms a physical barrier of about 30mm
that is able to keep bacteria at a distance from the epithelium
(Johansson et al., 2008). A mucus-eroding microbiota promotes
greater epithelial access (Desai et al., 2016). Prevotella, through
production of sulfatases that induce mucus degradation (Wright
et al., 2000), might impair themucosal barrier function and there-
fore contribute to better accessibility to intestinal epithelial cells
and to local inflammation. We thus compared the colonic mucus
layer thickness of conventional mice infected with WT Lm or
Dlmo2776 by confocal microscopy, using mucus-preserving
Carnoy fixation and FISH (Johansson and Hansson, 2012). The
average distance of bacteria from colonic epithelial cells was
significantly smaller in mice infected with Dlmo2776 compared
to mice infected with WT Lm at 24 and 48 h (Figures 4D and
4E), suggesting that Prevotella present in the microbiota of
mice infected with Dlmo2776 decreases the mucus layer thick-
ness and might consequently increase its permeability. Of
note, these distances were also smaller than in uninfected
mice, indicating that Lm infection itself affects the mucus layer
thickness. To confirm the effect of Pc on mucus layer in the
context of listerial infection, germfree C57BL/6J mice wereice inoculated with WT or Dlmo2776 strains. Each raw represents one mouse.
each phylum of the bacteria domain, together with OTUs showing significantly
2776 strains at day 1 (in red).
Dlmo2776 at day 0 and day 1.
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Figure 3. Lmo2776 Targets Pc in Human Microbiota and In Vitro
(A) Relative abundance of genera in SHIME vessels non-infected or infected with WT or Dlmo2776 strains. The four more abundant genera are indicated.
(B) Relative abundance of 7 different OTUs in SHIME vessels infected with WT or Dlmo2776 strains or non-infected. Each dot represents the value for one vessel.
(C) Phylogenetic tree of 16S rRNA gene alignment of several Prevotella species, together with OTUs showing significantly different relative abundances in vessels
inoculated with WT or Dlmo2776 strains at day 1 (in red).
(D) Levels of propionate in SHIME vessels infected with WT or Dlmo2776 strains or non-infected overtime. Results are expressed as mean ± SEM for 2 to 3
individual vessels.
(legend continued on next page)
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precolonized with Pc (DSMZ 18205 strain), Bt, or Ps, then orally
inoculated with WT Lm or Dlmo2776 strains; and mucus layer
thickness was analyzed by FISH. In mice precolonized with Pc,
the average distance of bacteria from colonic epithelial cells
was significantly smaller in Dlmo2776-infected mice compared
to WT Lm-infected mice (Figures 4F and 4G). Strikingly, such a
difference was not observed in germfree mice or in mice pre-
colonized with Ps or Bt, revealing that mucus erosion is depen-
dent on Pc.
Since the thinner mucus layer induced by Prevotella could
favor invasion of the host by bacteria and contribute to intestinal
inflammation, we quantified faecal lipocalin-2 (LCN-2) as a
marker of intestinal inflammation (Chassaing et al., 2012).
LCN-2 is a small secreted innate immune protein that is critical
for iron homeostasis andwhose levels increase during inflamma-
tion. Faecal LCN-2 levels were analyzed after colonization of
germfree mice with Pc compared to non-colonized mice or
mice colonized with Bt. A significant increase of faecal LCN-2
was observed in germfree mice monocolonized with Pc
compared to non-colonized animals or to animals monocolon-
ized with Bt (Figure 4H), revealing that Pc induces intestinal
inflammation. Altogether, these results showed that presence
of Prevotella in the intestine is associated with a thinner mucus
layer and increased levels of faecal LCN-2. They are consistent
with previous reports describing Prevotella as a bacterium pro-
moting a pro-inflammatory phenotype (Elinav et al., 2011;
Larsen, 2017; Scher et al., 2013).
DISCUSSION
Outcompeting intestinal microbiota stands among the chal-
lenging issues for enteropathogens. Pathogens may secrete
diffusible molecules such as bacteriocins or T6SS effectors to
target commensals and consequently promote colonization
and virulence. In most cases, molecular mechanisms underlying
the interplay between pathogenic and commensal bacteria in the
intestine remain elusive. We previously reported that most
strains responsible for human infections, such as the F2365
strain, secrete a bacteriocin that promotes intestinal colonization
by Lm (Quereda et al., 2016). When overexpressed in mouse gut,
this bacteriocin, named Listeriolysin S (LLS), decreases Allobac-
ulum andAlloprevotella genera known to produce butyrate or ac-
etate, two SCFAs reported to inhibit transcription of virulence
factors or growth of Lm (Ostling and Lindgren, 1993; Sun et al.,
2012). However, whether physiological concentrations of LLS
have a direct or an indirect role on these genera is still under
investigation and is a question particularly difficult to address
as LLS is highly post-translationally modified and therefore diffi-
cult to purify or to synthetize. In the case of Salmonella enterica
serovar Typhimurium infection, killing of intestinal Klebsiella oxy-(E) Numbers of Pc after incubation with supernatant of WT or Dlmo2776 strains.
(F) Relative abundance of Pc and Bt after 24 h incubation with increasing dose o
without Lmo2776 peptide.
(G) Relative abundance of different bacteria after 24 h incubation with Lmo2776 p
are expressed as mean ± SEM of a least 3 independent experiments and P
***p < 0.005).
(H) PCR quantification of Prevotella and Am in the feces of mice treated with Lmo
dot represents the value for one mouse. Statistically significant differences weretoca via its T6SS is essential for S. enterica gut colonization of
gnotobiotic mice colonized by K. oxytoca (Sana et al., 2016),
but whether K. oxytoca and other members of the gut microbiota
are targeted by the Salmonella T6SS in conventional mice is un-
known. Shigella sonnei uses a T6SS to outcompete E. coli in vivo
but the effectors responsible for this effect are unknown (Ander-
son et al., 2017).
Here, we report and provide evidence that the Lmo2776 Lm
bacteriocin targets Prevotella in mouse and in in vitro reconsti-
tuted human microbiota. This effect is direct and specific to
Pc, as (i) Pc are killed by Lm culture supernatant and by the
purified Lmo2776 in vitro and (ii) despite the complexity of
the microbiota and its well-controlled equilibrium, no other
genus of the intestinal microbiota was found to be impacted
by Lmo2776. By studying Lmo2776, we have unveiled a so-
far-unknown role for intestinal Pc in exacerbating bacterial
infection. The intestinal microbiota, in some cases, has already
been reported to promote bacterial virulence by producing
metabolites that enhance pathogens virulence gene expres-
sion and colonization in the gut (B€aumler and Sperandio,
2016; Rolhion and Chassaing, 2016). For example, Bt en-
hances Clostridium rodentium colonization by producing
succinate (Curtis et al., 2014; Ferreyra et al., 2014), and Am
exacerbates S. Typhimurium-induced intestinal inflammation
by disturbing host mucus homeostasis (Ganesh et al., 2013).
Pc decreases the mucus layer thickness and increases propi-
onate concentration and levels of fecal LCN-2, in agreement
with previous studies reporting that Pc exacerbates
inflammation (Elinav et al., 2011; Scher et al., 2013). In addi-
tion, Prevotella enrichment within the lung microbiome of
HIV-infected patients has been observed and is associated
with Th17 inflammation (Shenoy and Lynch, 2018). Prevotella
sp. have also been associated with bacterial vaginosis, and
their role in its pathogenesis has been linked to the production
of sialidase, an enzyme involved in mucin degradation and
increased levels of pro-inflammatory cytokines (Briselden
et al., 1992; Si et al., 2017). Together, our data strongly sug-
gest that Pc, by modifying mucus layer permeability and
changing the gut inflammatory condition, promotes greater
epithelial access and therefore infection by Lm (Figure 4I).
We can speculate that individuals with a high abundance of in-
testinal Prevotella might be more susceptible to enteric infec-
tions. Interestingly, it was recently shown that subjects with
higher relative abundance of Pc could be at higher risk to trav-
eler’s diarrhea and to the carriage of multidrug-resistant
Enterobacteriaceae (Leo et al., 2019). In addition, as
Lmo2776 bacteriocin allows a selective depletion of Pc in
the gut, it could prevent excessive inflammation and allow
Lm persistence and long-lasting infection, eventually leading
to meningitis. Further work is required to determine why Lmf Lmo2776 peptide (3 (+), 6 (++) and 9(+++) mg/mL) relative to their abundance
eptide (3mg/mL) relative to their abundance without Lmo2776 peptide. Results
values were obtained using two-tailed unpaired Student’s t test (*p < 0.05,
2776 peptide (1 mg) or with water relative to their levels before treatment. Each
evaluated by Student’s t test (**p < 0.01).
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Figure 4. Pc Controls Lm Infection by Modifying Mucus Layer and Promoting Inflammation
(A andB) Assessment of listerial CFUs in the intestinal luminal content (A) and in the spleen (B) of germfree (GF) C57BL/6Jmice colonized or not withPc, Ps orBt or
stably colonized with 12 bacterial species (Oligo-MM12) for 2 weeks and then inoculated with Lm WT or Dlmo2776 for 72 h.
(C) Numbers of Pc CFUs in the intestinal luminal content of GF C57BL/6J mice colonized with Pc and then inoculated with Lm WT or Dlmo2776 for 72 h.
(D) Confocal microscopy analysis of microbiota localization in colon of BALB/cmice infected with LmWT or Dlmo2776 bacteria for 24 or 48 h. Muc2 (green), actin
(purple), bacteria (red), and DNA (blue). Bar = 20 mm. White arrows highlight the 3 closest bacteria. Pictures are representatives of 5 biological replicates.
(E) Distances of closest bacteria to colonic intestinal epithelial cells per condition over 5 high-powered fields per mouse, with each dot representing a
measurement.
(legend continued on next page)
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strains have kept the lmo2776 gene. We showed here that the
Lmo2776 bacteriocin also targets Bs, a Gram-positive bacte-
rium found in the soil, suggesting that Lmo2776 could give
an advantage to Lm in that environment. It is possible that
Lmo2776 is critical for species survival and replication in a
so far unknown niche, consequently favoring transmission or
dissemination. Bs is also found in the human gastrointestinal
tract (Hong et al., 2009) and could be targeted by Lmo2776
in the intestine as well. Bs is also targeted by Sil, another
member of the Lcn972 family (Li et al., 2014). The role of the
homologs of Lcn972 in other human pathogenic bacteria
such as S. pneumoniae and S. aureus remains to be deter-
mined, but conservation of the bacteriocin in different patho-
genic bacteria associated with mucosa strongly suggests an
important role.
Taken together, our data reveal thatPc canmodulate intestinal
infection, and using Lmo2776 might represent an effective ther-
apeutic tool for Prevotella-related diseases to reduce Pc abun-
dance in the gut without affecting the remaining commensal
microbiota.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mucin-2 primary antibody Santa Cruz Biotechnology rabbit H-300
Bacterial and Virus Strains
EGD-e Listeria monocytogenes WT strain Mackanes, 1964 BUG 1600
EGD-e Dlmo2776
Listeria monocytogenes EGD-e lmo2776 deletion mutant
this study BUG 3713
EGD-e Dlmo2776 plmo2776 pAD-lmo2776 chromosomally
integrated in Dlmo2776
this study BUG 3717
F2365, Listeria monocytogenes strain associated with the
1985 listeriosis outbreak in California
Linnan et al., 1988 BUG 3012
10403S, Listeria monocytogenes WT strain Edman et al., 1968 BUG 1361
L. innocua Clip11262 ATCC ATCC 33091
Bacillus subtilis 168trpC2 Institut Pasteur Collection BUG 748
Escherichia coli Top10 Invitrogen C404003
Bacteroides thethaiotamicron Institut Pasteur Collection CIP 104206T
Lactococcus lactis IL14103 Gift from B. Martinez BUG 1801
Lactococcus lactis M1363 Gift from B. Martinez BUG 3029
Enterococcus faecalis ATCC ATCC 700802
Akkermensia muciniphila ATCC ATCC BA-835
Prevotella copri DSMZ DSMZ 18205
Prevotella salivae DSMZ DSMZ 15606
Prevotella oris Institut Pasteur Collection CIP 104480T
Prevotella nigrescens Institut Pasteur Collection CIP 105552T
Prevotella pallens Institut Pasteur Collection CIP 105551T
Prevotella corporis Institut Pasteur Collection CIP 105107T
Prevotella melanogenica Institut Pasteur Collection CIP 104591
Prevotella bivia Institut Pasteur Collection CIP 105105T
Chemicals, Peptides, and Recombinant Proteins
GTFWVTWGQDRHYSNYQHTKKTHRSSASNYRATERSSW
KAKNNLATAWIKSSLWGNKANWATK
Chemically synthetized
polypeptide for this study
N/A
Critical Commercial Assays
PowerSoilTM DNA Isolation Kit MOBiO 12888-50
Quant-iT PicoGreen dsDNA assay ThermoFischer P7589
Deposited Data
16S rRNA gene sequence data this study in the European Nucleotide
Archive database
(https://www.ebi.ac.uk/ena)
Experimental Models: Organisms/Strains
BALB/c mice Charles River 24980676
C57BL6/J mice Charles River 24980803
Oligonucleotides
All oligonucleotides are listed in Table S1. This study N/A
Recombinant DNA
pMAD(shuttle vector used for creating plasmid for mutagenesis) Arnaud et al., 2004 N/A
pAD (site-specific integration vector used for complementation) Lauer et al., 2002 N/A
plmo2776 lmo2776 complementation plasmid this study N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
GraphPad Prism 6.0 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
Microsoft Excel Microsoft https://products.office.com/en-us/excelLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents, including strains and plasmids generated in this study, should be
directed to and will be fulfilled by the Lead Contact, Pascale Cossart (pascale.cossart@pasteur.fr). All reagents generated in this
study are available from the Lead Contact.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial Strains and Plasmids
Strains, plasmids and primers used in this study are listed in in the Key Resources Table. For standard experiments, Listeria, E. coli,
Bs and L. lactis were grown at 37C with shaking in Brain Heart Infusion (BHI) medium (Difco) and Luria-Bertani (LB) medium (BD). If
needed, Lm were selected on Oxford medium (Oxoid). Anaerobic bacteria were grown in appropriate medium (PYG medium modi-
fied or Schaedler medium or BHI supplemented with 8mM L-Cysteine hydrochloride, 0.2% NaHCO3 and 0.025% Hemin, following
ATCC or DSMZ recommendations) at 37C under anaerobic conditions (Genbag Anaer, Biome´rieux or AnaeroGen, ThermoScien-
tific). The Lmo2776 deletion mutant was constructed using the pMAD shuttle plasmid (Arnaud et al., 2004) as described previously
(Mellin et al., 2013) and confirmed by DNA sequencing. For the construction of pAD-based plasmid, fragment obtained by PCR with
EGD-e genomic DNA as template, was cloned into the SmaI/SalI sites of the pAD vector (Balestrino et al., 2010) derived previously
from the pPL2 vector (Lauer et al., 2002). Plasmid was verified by sequencing with primers pPL2-Rv and pPL2-Fw and were trans-
formed into Dlmo2776 by electroporation. Integration in the chromosome was verified by PCR using primers NC16 and PL95
(Balestrino et al., 2010). Pc strains (AP1411, AQ1172, AQ1173, P54, K2152, T214 and A624) were isolated from stool from healthy
subjects and new onset rheumatoid arthritis patients. Stool was collected into anaerobic transport media (Anaerobe Systems),
then streaked on BRU and LKV plates (Anaerobe Systems). After 24-48 h, individual colonies were picked and screened with
Prevotella-specific PCR primers, and the 16S rRNA V3-V4 sequence was confirmed by Sanger sequencing (Fehlner-Peach et al.,
manuscript in preparation). Prevotella-positive isolates were grown on BRU plates, and glycerol stocks were frozen at 80C.
Mice
9- to 12-week-old female BALB/c conventional (Charles River) or C57BL6/J conventional (Charles River) or C57BL6/J germfree
(CDTA or Pasteur) or C57BL6/J stably colonized with a consortium of 12 bacterial species (termed Oligo-Mouse-Microbiota
(Oligo-MM12), representing members of the major bacterial phyla in the murine gut: Bacteroidetes (Bacteroides caecimuris and
Muribaculum intestinale), Proteobacteria (Turicimonas muris), Verrucomicrobia (Am), Actinobacteria (Bifidobacterium longum subsp.
Animalis) and Firmicutes (Enterococcus faecalis, Lactobacillus reuteri, Blautia coccoides, Flavonifractor plautii, Clostridium clostridio-
forme, Acutalibacter muris and Clostridium innocuum) (Brugiroux et al., 2016)) mice were used for experiments. Germfree and
Oligo-MM12 mice were housed in plastic gnotobiotic isolators.
All animal experiments were carried out in strict accordance with the French national and European laws and conformed to the
Council Directive on the approximation of laws, regulations, and administrative provisions of the Member States regarding the pro-
tection of animals used for experimental and other scientific purposes (86/609/Eec). Experiments that relied on laboratory animals
were performed in strict accordance with the Institut Pasteur’s regulations for animal care and use protocol, which was approved
by the Animal Experiment Committee of the Institut Pasteur (approval no. 03-49).
METHOD DETAILS
Mice Infection
Lm overnight cultures were diluted in BHI and bacteria were grown to an optical density at 600 nm (OD600) of 1. Bacterial cultures
were centrifuged at 3,5003 g for 15 min and washed three times in phosphate-buffered saline (PBS). Mice were infected orally with
53 109 bacteria diluted in 200 ml of PBS supplemented with 300 ml of CaCO3 (50 mg/mL). Serial dilutions of the inoculumwere plated
to control the number of bacteria inoculated. The different inoculum were closed to 5 3 109 bacteria and the mean ± SEM of all in-
dependent experiments were: for WT: 5.033 109 ± 0.263 109, for Dlmo2776: 5.013 109 ± 0.143 109 (p = 0.45) or Lmo2776 com-
plemented strain: 4.873 109 ± 0.303 109 (p = 0.25). Mice were killed at subsequent time points, and intestines, spleens, and livers
were removed. The small intestine was opened, and the luminal content was recovered in a 1.5-mL tube and weighed. The small
intestine (duodenum, jejunum, and ileum) tissue was washed four times in DMEM (ThermoFisher), incubated for 2 h in DMEMCell Host & Microbe 26, 691–701.e1–e5, November 13, 2019 e2
supplemented with 40 mg/mL gentamycin, and finally washed four times in DMEM. All of the organs and the intestinal luminal content
were homogenized, serially diluted, and plated onto BHI plates or Oxford plates and grown overnight at 37C for 48–72 h. CFU were
enumerated to assess bacterial load. At least three independent experiments were carried out with four or fivemice per group in each
experiment. Statistically significant differences were evaluated by the Mann–Whitney test, and differences were considered statis-
tically significant when P values were < 0.05.
For mice colonization, Pc, Ps and Bt were grown to log phase under anaerobic conditions in PYG modified or Schaedler broth
media and 107 CFU were used to inoculate germ-free mice. Feces were collected at 2 weeks post-gavage to confirm colonization.
Feces were homogenized, serially diluted and plated on PYG modified, Schaedler or Columbia agar plates.
Six- to 8-week-old female BALB/c mice (Charles River, Inc., France) were injected intravenously with 5.103 CFU of the indicated
strain. Mice were sacrificed at 72 h after infection, and livers and spleens were removed. Organs were homogenized and serially
diluted. Dilutions were plated onto BHI plates and grown during 24 h at 37C. Colonies were counted to assess bacterial load
per organ.
Fecal Microbiota Analysis by 16S rRNA Gene Sequencing Using Illumina Technology
Before infection, 8 BALB/c conventional micewere co-housed for 5weeks in order to stabilize and homogenize their microbiota. After
oral infection, animals were single-housed. Feces were collected and frozen at20C. 16S rRNA gene amplification and sequencing
were done using the Illumina MiSeq technology following the protocol of Earth Microbiome Project with their modifications to the
MOBIO PowerSoil DNA Isolation Kit procedure for extracting DNA (Caporaso et al., 2012; Gilbert et al., 2010). Bulk DNA were ex-
tracted from frozen extruded feces using a PowerSoil DNA Isolation kit (MoBio Laboratories) with mechanical disruption (bead-
beating). The 16S rRNA genes, region V4, were PCR amplified from each sample as described in Chassaing et al., 2015 (Chassaing
et al., 2015). Four independent PCRs were performed for each sample, combined, purified with Ampure magnetic purification beads
(Agencourt), and products were visualized by gel electrophoresis. Productswere then quantified (BIOTEK Fluorescence Spectropho-
tometer) using Quant-iT PicoGreen dsDNA assay. A master DNA pool was generated from the purified products in equimolar ratios.
The pooled products were quantified using Quant-iT PicoGreen dsDNA assay and then sequenced using an Illumina MiSeq
sequencer (paired-end reads, 2 3 250 bp) at Cornell University (Ithaca, USA).
Bacterial Quantification in Feces
Bulk DNA were extracted from frozen extruded feces using a PowerSoil DNA Isolation kit (MoBio Laboratories) with mechanical
disruption (bead-beating). q-PCR reactions were prepared with SYBR Green master mix. Reaction cycling and quantification was
carried out in anC1000 touch Thermal cycler (CFX384, Biorad). Genomic DNA fromPrevotellawas used to generate a standard curve
to quantitate pg of Prevotella present per mg of total feces.
M-SHIME
M-SHIME system is a dynamic in vitromodel which simulates the lumen-associated and mucus-associated human intestinal micro-
bial ecosystem (ProDigest, Ghent University, Belgium) (Geirnaert et al., 2015; Van den Abbeele et al., 2013; Van den Abbeele et al.,
2012). It consists of consecutive pH-controlled, stirred, airtight, double-jacketed glass vessels kept at 37C and under anaerobic
conditions. The system was operated as described earlier (Chassaing et al., 2017) with minor modifications The set-up used here
consisted of 3 stomach-small intestine vessels and 9 proximal colon vessels in parallel (3 for non-infected condition, 3 for infection
withWT and 3 for infection withDlmo2776). The colon vessels were inoculated at the start with 40mL fresh human faecal suspension,
from a healthy volunteer with high levels of Prevotella, in 500 mL sterile nutritional medium. Every 2 days, half of the mucin agar-
covered microcosms were replaced by fresh sterile ones under a flow of N2 to prevent disruption of anaerobic conditions. Fourteen
days after inoculation, 3 colon vessels were infected with 106 WT bacteria, 3 colon vessels with 106 Dlmo2776 and 3 were left un-
infected. Lumen (10 ml) and mucin agar samples were taken at 6, 24, 48 and 72 h. Mucin agar-covered microcosms were washed
with sterile PBS to remove lumen bacteria. Mucin agar was removed from microcosms, homogenized and stored immediately at
20C until further analysis.
For 16S rRNA Gene Sequencing, DNA was extracted from 1 mL of lumen samples or 250 mg of mucin agar samples using a
PowerSoil DNA Isolation kit and 16S rRNA gene sequencing was analyzed as decribed above.
Our full 16S rRNA gene sequence data are deposited under Study ID PRJEB34638 in the European Nucleotide Archive database
(https://www.ebi.ac.uk/ena).
For SCFA analysis, lumen samples were diluted 1:2 in demineralized water. Acetate, propionate, butyrate, isobutyrate and isoval-
erate were extracted and quantified as described (De Weirdt et al., 2010).
RNA Extraction and qRT-PCR
A total of 25 mL cultures of bacteria, grown in BHI, was pelleted for 20 min at 3000 g. Pellets were resuspended in 1 mL TRI Reagent
(Sigma), transferred to 2 mL Lysing Matrix tubes (MP Biomedicals) and mechanically lysed by bead beating in a FastPrep apparatus
(twice 45 s, speed 6.5). Tubes were then centrifuged for 5 min at 8000 g at 4C to separate beads from lysates. The lysates were
drawn off and transferred to a 2 mL Eppendorf tube. 200 uL chloroform was added to the lysate, shaken and incubated 10 min at
room temperature, followed by centrifugation for 15 min at 13 000 g at 4C. The aqueous phase was transferred to a new tube
and RNA was precipitated by the addition of 500 uL isopropanol and incubation at room temperature for 10 min. RNA was pelletede3 Cell Host & Microbe 26, 691–701.e1–e5, November 13, 2019
by centrifuging for 10 min at 13000 g at 4C, washed twice with 75% ethanol. RNA pellets were resuspended in 50 to 100 uL water.
For each sample, 10 ug of RNA was treated with Dnase (Turbo DNA-free, Ambion) following manufacturer’s instructions. cDNA was
synthetiszed from 1 ug of RNA using QuantiTect Reverse Transcription (QIAGEN) and reactions were subsenquently diluted with
180 ul of water. qRT-PCR reactions were prepared with SYBR Green master mix. Reaction cycling and quantification was carried
out in an C1000 touch Thermal cycler (CFX384, Biorad). Expression levels were normalized to the rpoB gene. Samples were evalu-
ated in triplicate and results represent at least three independent experiments.
Co-cultures and Culture in Presence of Supernatant or Lmo2776 Peptide
For co-culture assays with Bs, a mixture of equivalent CFU (107) of Bs and Lm (WT, Dlmo2776 or p2776) was inoculated into 5 mL of
fresh BHI and incubated at 37C for 6 h. Serial dilutions were plated on BHI and on Oxford media for CFU enumeration.
For culture of target in presence of Listeria supernatant, 25 mL of overnight culture of Listeria were centrifuged at 13000 g and the
supernatants were collected and centrifuged further to remove cells and cells debris. Supernatants were filtered through a 0.20mm
pore size filter (Millipore). 107 bacterial targets (Bs, E. coli orPc) were inoculated at 37C into 2.5mL of listerial supernatant and 2.5mL
of fresh medium (BHI for Bs, LB for E. coli and PYG modified for Pc). At 16 h after inoculation (in aerobic conditions for Bs and E. coli
and in anaerobic conditions for Pc), cultures were serially diluted and plated on medium.
For in vitro assays, a peptide of 63aa (GTFWVTWGQDRHYSNYQHTKKTHRSSASNYRATERSSWKAKNNLATAWIKSSLWGN
KANWATK), corresponding to the putative mature form of Lmo2776 has been chemically synthesized (Polypeptide) and diluted.
107 bacteria were inoculated in absence or in presence of different concentrations of this peptide at 37C into 5 mL of medium. At
16 h after inoculation (in aerobic or anaerobic conditions), cultures were serially diluted and plated.
For in vivo assays, conventional mice were anaesthetized with an intraperitoneal injection of 75 mg ketamine kg1 and 5 mg
xylazine kg1. One hundred ul of Lmo2776 peptide (1mg in 100ml distilled H2O) was introduced rectally using a flexible catheter
into each of 12 test mice and 100ml distilled H2O was introduced into each of 6 control mice. Feces were collected between 1
and 4 h following the introduction. Bacteria were quantified as described above.
Immunostaining of Mucins and Localization of Bacteria by FISH
Colonic mucus immunostaining was paired with fluorescent in situ hybridization (FISH), as previously described (Chassaing et al.,
2017; Johansson and Hansson, 2012). Briefly, colonic tissues (proximal colon, 2nd cm from the cecum) containing fecal material
were placed in methanol-Carnoy’s fixative solution (60% methanol, 30% chloroform, 10% glacial acetic acid) for a minimum of
3 h at room temperature. Tissues were then washed in methanol 2 3 30 min, ethanol 2 3 15 min, ethanol/xylene (1:1) 15 min and
xylene 2 3 15 min, followed by embedding in Paraffin with a vertical orientation. Five mm sections were performed and dewax by
preheating at 60C for 10 min, followed by xylene 60C for 10 min, xylene for 10 min and 99.5% ethanol for 10 min. Hybridization
step was performed at 50C overnight with EUB338 probe (50-GCTGCCTCCCGTAGGAGT-30, with a 50 labeling using Alexa 647)
diluted to a final concentration of 10 mg/mL in hybridization buffer (20 mM Tris–HCl, pH 7.4, 0.9 M NaCl, 0.1%SDS, 20% formamide).
After washing 10 min in wash buffer (20 mM Tris–HCl, pH 7.4, 0.9 M NaCl) and 33 10min in PBS, PAP pen (Sigma-Aldrich) was used
tomark around the section and block solution (5% fetal bovine serum in PBS) was added for 30min at 4C.Mucin-2 primary antibody
(rabbit H-300, Santa Cruz Biotechnology, Dallas, TX, USA) was diluted 1:1500 in block solution and apply overnight at 4C. After
washing 33 10 min in PBS, block solution containing anti-rabbit Alexa 488 secondary antibody diluted 1:1500, Phalloidin-Tetrame-
thylrhodamine B isothiocyanate (Sigma-Aldrich) at 1 mg/mL and Hoechst 33258 (Sigma-Aldrich) at 10 mg/mL was applied to the
section for 2 h. After washing 3 3 10 min in PBS slides were mounted using Prolong anti-fade mounting media (Life Technologies,
Carlsbad, CA, USA). Observations were performed with a Zeiss LSM 700 confocal microscope. The software Zen 2011 version 7.1
was used to measure the distance between bacteria and epithelial cell monolayer.
Quantification of Fecal Lcn-2 by ELISA
Fecal samples were weighted, reconstituted in PBS-0.1% Tween 20 to a final concentration of 100 mg/mL and homogenized. Sam-
ples were then centrifuged for 10 min at 14 000 g and 4C and supernatants were collected and stored at20C until analysis. Lcn-2
levels were measured using DuoSet mouse Lipocalin-2/NGAL ELISA kit (R&D Systems).
Core genome MLST
lmo2774, lmo2775, lmo2776 genes were screened in a collection of 1,696 publicly available genomes (Moura et al., 2016)represen-
tative of the diversity of lineages and sublineages of Lm. Genes were detected using the BLASTn algorithm implemented in BIGSdb-
Lm platform v.1.17 (https://bigsdb.pasteur.fr/listeria; (Jolley and Maiden, 2010; Moura et al., 2016), with minimum nucleotide identity
of 70%, alignment length coverage of 70% and word size of 10.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical Analysis
Statistically significant differences were evaluated by Mann–Whitney test, one way-ANOVA test or two-tailed unpaired Student’s
t test using Excel or Prism software. Statistical details of experiments and statistical tests are reported and described in the figure
legends. Differences denoted in the text as significant fall below a p value of 0.05.Cell Host & Microbe 26, 691–701.e1–e5, November 13, 2019 e4
DATA AND CODE AVAILABILITY
16S rRNA Gene Sequence Analysis
Analysis of the 16S rRNA gene sequence was performed exactly as previously described (Chassaing et al., 2015). Our full 16S rRNA
gene sequence data are deposited under Study ID PRJEB34638 in the European Nucleotide Archive database (https://www.ebi.ac.
uk/ena).e5 Cell Host & Microbe 26, 691–701.e1–e5, November 13, 2019
